Geron Shares Outstanding vs. Current Valuation
| GERN Stock | USD 4.12 0.05 1.20% |
For Geron profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Geron to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Geron utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Geron's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Geron over time as well as its relative position and ranking within its peers.
Geron |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 0.047 | Quarterly Revenue Growth 171.384 | Return On Assets (0.30) | Return On Equity (0.69) |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Geron Current Valuation vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Geron's current stock value. Our valuation model uses many indicators to compare Geron value to that of its competitors to determine the firm's financial worth. Geron is one of the top stocks in shares outstanding category among its peers. It is rated below average in current valuation category among its peers reporting about 3.70 of Current Valuation per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Geron's earnings, one of the primary drivers of an investment's value.Geron Current Valuation vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Geron |
| = | 604.5 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Geron |
| = | 2.24 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Geron Current Valuation vs Competition
Geron is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 34.78 Billion. Geron holds roughly 2.24 Billion in current valuation claiming about 6% of equities under Health Care industry.
Geron Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Geron, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Geron will eventually generate negative long term returns. The profitability progress is the general direction of Geron's change in net profit over the period of time. It can combine multiple indicators of Geron, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 185 K | 194.2 K | |
| Operating Income | -193.9 M | -184.2 M | |
| Income Before Tax | -184.1 M | -174.9 M | |
| Total Other Income Expense Net | 9.8 M | 10.3 M | |
| Net Loss | -184.1 M | -174.9 M | |
| Income Tax Expense | 1.00 | 0.95 | |
| Net Loss | -184.1 M | -174.9 M | |
| Non Operating Income Net Other | 4.1 M | 4.3 M | |
| Net Loss | -127.7 M | -121.3 M | |
| Interest Income | 18.2 M | 19.1 M | |
| Net Interest Income | 9.8 M | 10.3 M | |
| Change To Netincome | 9.5 M | 7.1 M | |
| Net Loss | (0.32) | (0.34) | |
| Income Quality | 0.91 | 0.54 | |
| Net Income Per E B T | 1.14 | 1.11 |
Geron Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Geron. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Geron position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Geron's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Geron without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Use Investing Themes to Complement your Geron position
In addition to having Geron in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Israel Wall Street Thematic Idea Now
Israel Wall Street
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
To fully project Geron's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Geron at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Geron's income statement, its balance sheet, and the statement of cash flows.